Mergers & Acquisitions Mergers & Acquisitions

AstraZeneca, Alexion need antitrust approval from 13 jurisdictions, including US, EU, UK, Brazil, South Korea, Japan

By Flavia Fortes
  • 10 Mar 2021 10:54
  • 15 Mar 2021 06:13
AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals needs clearance from antitrust authorities from 13 jurisdictions, including the United States, the European Union, the UK, Brasil, South Korea and Japan.

Canada, Colombia, Israel, Morocco, Russia, Taiwan and Turkey are also on the list, which was disclosed by the companies in their filing with the

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News